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ABSTRACT
Two experiments studied the effects of pretreatment with estradiol benzoate before
treatment with a dopamine antagonist on prolactin secretion and reproductive traits in mares
during 1) the seasonal anovulatory period and 2) the normal breeding season. Experiment 1
was performed in winter with 17 mares selected for low follicular activity. Nine mares received
estradiol benzoate injections every other day for a total of 10 injections; 8 mares received
similar injections of vehicle. Ten days after onset of injections, all mares were placed on a daily
injections of sulpiride (250 mg) for 45 d or until ovulation. Plasma prolactin concentrations
were higher (P < 0.001) in mares receiving estradiol than in control mares for all assessments
from d 12 through 36. Mean day of ovulation was 73.6 d for control mares and 29.0 for
estradiol-treated mares (P = 0.016). It was concluded that estradiol treatment greatly enhanced
prolactin secretion in response to sulpiride in seasonally anovulatory mares and hastened the
date of first ovulation by an average of 45 d. Experiment 2 was designed to assess the efficacy
of a single injection preparation of another dopamine antagonist, domperidone, for increasing
prolactin secretion in cyclic mares in the summer. The experimental design and procedures
used in Experiment 1 were repeated, except that a single shot of 3 g of domperidone was
administered on d 11 rather than 45 d of sulpiride injections. Day 0 was the first day of estrus
for each mare. Prolactin concentrations were higher (P < 0.05) in mares receiving estradiol than
in control mares from d 12 through 25 and after a thyrotropin releasing hormone injection on d
21. It was concluded that estradiol enhanced the prolactin response to a single injection of 3 g
of domperidone in cyclic mares in the summer in a manner similar to the estradiol enhancement
of prolactin secretion in response to daily sulpiride injections in anovulatory mares in winter.
Thus, the single injection of domperidone could possibly replace the daily sulpiride injections
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used in Experiment 1 to induce ovulation in seasonally anovulatory mares; this needs to be
tested in future experiments.
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INTRODUCTION
Prolactin is a pituitary hormone primarily thought to regulate lactation; however,
previous research has indicated that it is also actively involved in reproduction in mares.
Horses are seasonally reproductive animals, experiencing estrous cycles during the spring and
summer months and a period of ovarian inactivity during the winter (Ginther, 1992; Daels and
Hughes, 1993). Thompson et al. (1986) reported that horses have higher prolactin levels during
the breeding season, with mares having the highest levels. Mares undergoing transition from
the anovulatory season in winter to the breeding season experience increases in several
hormones, including prolactin. This “transition” period may also involve the development and
growth of large follicles for a long period of time without ovulation (Sharp and Davis, 1993).
Concentrations of luteinizing hormone (LH) remain low until the first pre-ovulatory surge
(Hines et al., 1991). Hines et al. (1991) also showed that the mare will often have long erratic
displays of estrus towards the stallion during this time.
Because most breed associations use the single-date, January 1 birth date for all foals
born in a calender year, many horse breeders invest considerable time and effort into getting
broodmares pregnant around February 15th, so that the resulting foals will be born around, but
not before, January 1st of the following year. It is thought by many that these “early-born” foals
will have a physical advantage over foals born later in the spring. That is, a foal born January
1st would have a 5-mo size advantage over a foal born June 1st at a yearling sale the following
year. Thus, a simple and economical method of inducing ovarian activity and ovulation in
February is desirable. Moreover, avoiding the erratic estrous cycles typical of the transition
period is also a common goal of breeders in February.
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Several research groups have shown that increasing prolactin in mares in winter aids in
the development of follicles and, in some cases, ovulation. Besognet et al. (1997) and Redmond
et al. (1997) reported an increase in prolactin concentrations after administration of either of
two dopamine antagonists, sulpiride or domperidone. Donadeu and Thompson (2002) reported
that treatment of anovulatory mares with sulpiride increased prolactin levels but did not
adequately stimulate follicular development in the winter. Nequin et al. (1993) reported that
increases in prolactin levels during the winter, either by a dopamine antagonist administration
or by injection of bovine prolactin, stimulated follicular growth positively and rapidly. In
addition, Thompson et al. (1991) reported that administration of recombinant porcine prolactin
daily to seasonally anovulatory pony mares resulted in ovulation or corpus luteum (CL)
formation within 21 d.
One explanation for mediocre or poor stimulation of follicular activity in mares in
winter treated with sulpiride (Besognet et al., 1997; Donadeu and Thompson, 2002) has been
inadequate prolactin secretion in response to the sulpiride injections. Thompson and Depew
(1997) showed that prolactin responses to daily sulpiride injections in geldings in winter
dropped quickly after the first injection, indicating that prolactin production by the pituitary was
likely not stimulated. One missing factor in seasonally anovulatory mares (and geldings) that
may account for the poor prolactin response to sulpiride is estrogen, which has been reported to
increase prolactin production and secretion in ovariectomized mares in summer (Thompson et
al., 1991). Thus, the objective of the first experiment presented herein was to test whether
pretreatment with estradiol benzoate before treatment with daily sulpiride injections would
enhance the prolactin response, and hence the ovarian response, of seasonally anovulatory
mares. Given the positive response to estradiol observed in the first experiment, the second

2

experiment was designed to test whether estradiol pretreatment would enhance the prolactin
response to a single, 3-g injection of domperidone, which could potentially be used in lieu of
daily sulpiride injections in the winter stimulatory regimen. Experiment 2 was performed in
summer with normally cyclic mares.
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CHAPTER I
REVIEW OF LITERATURE
Hypothalamic-pituitary axis
Extensive research has been conducted on the hypothalamic-pituitary gonadal axis that
strongly reinforces the idea that it is a prominent key in reproduction. The hypothalamus
accumulates information from outside stimuli and converts those neural signals into hormonal
signals (Guyton and Hall, 1996). The hypothalamus produces the essential regulatory hormone
of reproduction: gonadotropin releasing hormone (GnRH), which is localized evenly in all areas
of the hypothalamus in mares (Irvine and Alexander, 1993). Secretory granules release GnRH
into capillaries of the primary plexus; this released GnRH travels to receptors on gonadotropes
in the pars distalis in the adenohypophysis of the pituitary via the hypophysial portal veins
(Alexander and Irvine, 1993; Kainer, 1993).
Gonadotropin releasing hormone stimulates production of its own receptors on
gonadotropes (Clayton, 1989; Alexander and Irvine, 1992). Gonadotropin releasing hormone
also stimulates LH and follicle stimulating hormone (FSH) production and secretion in the
adenohypophysis, which further affect reproduction in the horse. Free GnRH receptors limit the
action of GnRH; estradiol can induce more receptors (Alexander and Irvine, 1993).
The hypothalamus secretes GnRH in pulses lasting 5 to 25 min occurring every 1 to 2 h
(Guyton and Hall, 1996). This is suggested to control the differential release of the
gonadotropins (Dyer, 1989; Ginther, 1992). Luteinizing hormone production and secretion
correspond with rapid pulses (e.g., every 45 min), while pulses every 6 h results in mainly FSH
secretion (Alexander and Irvine, 1993). This relates to the fact that, during estrus, GnRH pulses
are increased to 2/h and LH is high while FSH is low. In contrast, during diestrus, GnRH pulses

4

occur an average of 2/d while FSH is increased and LH is decreased (Alexander and Irvine,
1993).
The two gonadotropins exert their effect through extracellular receptors on the ovaries.
Receptors for FSH are found on granulosa cells and receptors for LH are found on thecal cells
of pre-antral follicles (Alexander and Irvine, 1993).
Estrous cycle in the mare
In relation to breeding, the mare has two phases that make up the well-known estrous
cycle: estrus and diestrus. The estrous cycle is from the start of one estrus to the start of the
next (Daels and Hughes, 1993). The cycle is controlled by daylight and environmental effects
(Ginther, 1992); the average estrous cycle is 21.7 d, ranging from 19.1 to 23.7 d. During the
estrous cycle, the phase in which follicular growth is most prominent is estrus (Daels and
Hughes, 1993). The period between ovulation and the onset of the next estrus is known as
diestrus (Daels and Hughes, 1993). The average lengths for estrus and diestrus are 6.5 and 15.2
d, respectively. During estrus, FSH stimulates follicles; upon selection of a dominant follicle,
estrogen is produced, causing expression of estrous behavior. Increased LH concentrations
result in ovulation of the oocyte from the dominant follicle 24 to 48 h before the end of estrus.
Development of a CL begins after ovulation.
The CL begins the diestrous phase by secreting increased amounts of progesterone
(Daels and Hughes, 1993). During diestrus, the mare is unreceptive to the stallion. The
increased levels of progesterone feed back negatively on the pituitary gland causing decreased
LH secretion (Miller et al., 1980). Plasma concentrations of LH peak 1 d post-ovulation before
decreasing. High levels of FSH occur in diestrus and are due to the lack of negative feedback
by estradiol and inhibin (Freedman et al., 1979). Towards the completion of diestrus, the CL
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regresses due to lysis by prostaglandin F2α (PGF2α), and the mare returns to estrus in 1 to 3 d
(Daels and Hughes, 1993).
Seasonality
Mares are seasonally polyestrous, meaning they have multiple estrous cycles during
summer months and become acyclic in the winter (Daels and Hughes, 1993). If a mare is not
bred during the breeding season, she will display several repeated periods of estrus (Sharp and
Davis, 1993).
The period from a mare's last ovulation of a particular breeding season until the first
ovulation of the next is considered the anovulatory season (Ginther, 1992). The anovulatory
season is characterized by three phases. The first, in which large follicles may form but fail to
ovulate, is known as the receding phase (Ginther, 1992). The second, in which very few
follicles grow beyond 10 to 20 mm, is the inactive phase. Finally, the resurging phase is the
beginning of recovery from the inactive phase. During the receding phase, follicles fail to
ovulate due to insufficient LH secretion needed for ovulation (Snyder et al., 1979). This period
can also be defined as sexual incompetence and indifference during winter months according to
Sharp and Davis (1993). They also explain that this lack of reproductive activity is due to a
decrease in GnRH secretion. Thompson et al. (1986, 1987) reported a distinct suppression of
secretion of the gonadotropins in the winter months. Some mares may display weak signs of
estrus during the inactive phase, even when follicular growth is absent (Ginther, 1992; Gentry et
al., 2002).
When a mare begins to return to the ovulatory season and begin a period of long
follicular growth before ovulation, she is said to be in the resurging phase, or vernal (spring)
transition. Sharp and Davis (1993) reported the length of the time between the initial increase

6

in FSH and first ovulation to be lengthy. Concentrations of FSH fluctuate, but LH remains low
until right before the first ovulation (Hines et al., 1991). Freedman et al. (1979), Silvia et al.
(1986), and Hines et al. (1991) all reported a decrease in the FSH pulse amplitude as the first
ovulation approached, due to the increased production of inhibitory factors (estradiol and
inhibin) from the large follicles (Miller et al., 1981). During vernal transition, LH release is
stimulated by increasing GnRH concentrations, along with steroidogenically competent
follicles, which result in a peripheral increase in estrogen concentrations (Sharp and Davis,
1993). The increasing estradiol levels positively feedback to stimulate more LH secretion.
When sufficient LH has been secreted for a sufficient amount of time, ovulation occurs.
Folliculogenesis and follicular waves
A mare's ovary contains many follicles, which are the basic units of germ cell
development. The ovary has both endocrine and exocrine functions (Pierson, 1993). Hormones
are released into circulating blood that perfuses the follicles. The ovary is also controlled by
local intercellular diffusion, called paracrine control, and release of substances that bind the
cell's own receptors, otherwise known as autocrine control (Pierson, 1993).
The physical aspect of follicle formation and gradual development up to ovulation is
referred to as folliculogenesis. The mare, like other mammalian females, is born with a fixed
number of unreplenished follicles (Ginther, 1992). These follicles are simply an oocyte
surrounded by a layer of cells. Follicular growth also includes oocyte growth, development of a
zona pellucida, and then division of granulosa cells into epithelium (Pierson, 1993).
Development to this stage (10 mm in diameter) is not controlled by gonadotropins (Pierson,
1993). Thereafter, without LH and FSH, follicles become atretic.
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Many follicles grow and regress without ever ovulating, making size an important
factor. Ginther (1992) described three major sizes (diameters) of ovarian follicles: small (2 to
10 mm), medium (11 to 24 mm) and large ($25 mm). The number of small follicles is little in
the preovulatory stage when compared to the increased number during a postovulatory stage
(Pierson, 1993). During the luteal phase, FSH increases the number of small follicles (Ginther
and Bergfelt, 1993). Ginther et al. (2001) explained that after a follicle reaches 13 mm, FSH
decreases and estradiol, free IGF-1, activin-A, and inhibin-A begin to increase differentially.
This allows for deviation of a dominant follicle with more responses to LH and FSH. This
deviation begins after the two largest follicles reach an average 19.0 to 22.5 mm. As the
dominant follicle grows and produces more estradiol and inhibin, it causes atresia of the other
medium and large follicles (Ginther, 1992; Pierson, 1993).
The emergence of small follicles and growth to medium follicles appears to occur in
“waves” in mares, as has been reported for other species (Ginther, 1992; Pierson, 1993).
Pierson (1993) attributes these waves to bimodal and unimodal surges in FSH concentrations
during diestrus. Ginther and Bergfelt (1993) also state that follicular waves are due to FSH
levels. Ginther (1992) defines these types of actions as several follicles initially growing in
synchrony (same size and rate), but they eventually dissociate to allow a dominant follicle. All
mares have at least 1 follicular wave, while some mares have 2 follicular waves, per estrous
cycle. The secondary wave is the first wave to take place after ovulation, generally during early
diestrus. The dominant follicle from this wave rarely ovulates, but usually regresses. The
primary wave eventually produces a new dominate follicle that will ovulate independently from
the first wave. This follicle is more responsive to steroid and gonadotropin stimulation due to
increased receptors for FSH and LH on the granulosa and theca cells (Pierson, 1993).
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Ovulation and the luteal phase
Ovulation starts the luteal phase in the mare. During the start of this phase, the
granulosa cells of the dominate follicle lutienize, and by d 3, a CL is formed (Niswender and
Nett, 1993). The CL then produces progesterone throughout its life span. Progesterone
increases receptors for LH so that LH can continually be utilized for support by the CL. By d 9,
progesterone has reached a maximum, along with maximum growth of the CL. If the mare is
not pregnant, the uterus will begin secreting PGF2α around d 13 or 14, which will cause
regression of the CL and a drop in progesterone secretion. This marks the end of the luteal
phase and begins the next estrous cycle.
Prolactin
Prolactin is a single-chain protein made up of 199 amino acids (Nett, 1993). It is a
hormone produced in the lactotropes of the adenohypophysis (Hadley, 2000). Prolactin is
usually associated with pregnancy and lactation, and it has only recently been associated with
reproductive functions in males and non-pregnant females of several species. Prolactin has a
wide range of biological actions in various species. In 1928, Stricker and Grueter (cited by
Hadley, 2000) observed a direct action of prolactin by using an extract of the anterior pituitary
to stimulate milk secretion in rabbits. In 1933, Riddle, Bates, and Dykshorn (cited by Hadley,
2000) first observed that growth of crop sacs in pigeons was stimulated by bovine pituitary
extracts, and they named the hormone prolactin. In many species, prolactin has effects on
sebaceous glands, luteal tissue, and pelage, along with the prominent action in mammary glands
(Hadley, 2000). Prolactin has often been referred to as the "maternity hormone" after its major
role in pregnancy and lactation. Lactotropes make up 6.5% to 16.5% of the equine pituitary
gland (Rahmanian et al., 1997). When prolactin was injected directly into ducts
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of the mammary gland, only alveoli around the site of injection produced milk, suggesting that
prolactin needs actions from other hormones as well.
Prolactin increases at puberty, but only to a minor degree compared with LH and FSH.
Also, the estrogen experienced at puberty is stimulatory to prolactin secretion. Prolactin has
been shown to have profound effects on LH, and may influence it during puberty. Prolactin has
been shown to increase LH receptors on Leydig cells in males (Purvis and Hassen, 1978; Bartke
et al., 1980; Van Stralen and Zeilmaker, 1982) and on granulosa and luteal cells of females
(Jones and Hsueh, 1981; Van Straalen and Zeil, 1982). In male rats, prolactin treatment
prevents loss of LH receptors on Leydig cells. In stallions, prolactin may regulate seminal
volume (Thomson et al., 1996). Prolactin is also responsible for hair shedding in horses
(Thompson et al., 1997) and sheep (Lincoln and Tortonese, 1995).
In horses, Roser et al. (1987) showed that equine prolactin secretion is episodic in nature.
Johnson (1986) reported an increase in prolactin concentration during the breeding season, and
mares had an even greater increase in prolactin concentrations than stallions or geldings
(Thompson et al., 1986). Prolactin concentrations in horses are directly correlated with
photoperiod and temperature (Johnson, 1986; Thompson and Johnson, 1987). Increasing
photoperiod during winter hastened the onset of increased prolactin concentrations (Johnson,
1987). Fitzgerald and McManus (2000) showed that increased melatonin during short
photoperiod decreased prolactin concentration.
Prolactin is primarily regulated by dopamine secreted from the hypothalamus (Hadley,
2000). Dopamine is said to be the prolactin inhibiting factor (Neill et al., 1981; Ben Jonathan,
1985). Lactotropes removed from hypothalamic input secrete large amounts of prolactin
(Hadley, 2000). This is because they spontaneously depolarize and secrete prolactin without
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the tonic inhibition from dopamine (Hadley, 2000). Thomson et al. (1996) reported the
inhibitory effects on prolactin concentrations in stallions by the dopamine agonist,
bromocriptine. In female rats, suppression of prolactin with bromocriptine retarded normal
follicular development and delayed puberty (Advis et al., 1981). Opioid peptides may also play
a physiological role in controlling the release of pituitary hormones (Hadley, 2000).
Endogenous opioid peptides inhibit dopaminergic pathways that control hormones from the
hypothalamus, such as prolactin (Hadley, 2000).
In most mammalian species studied, prolactin is secreted in response to the
hypothalamic thyroid regulating hormone, thyrotropin releasing hormone (TRH); this
apparently is via specific receptors for TRH on lactotropes (Gerschengorn et al., 1979).
Administration of TRH has been shown to increase plasma prolactin concentrations in horses as
well (Johnson, 1986; Johnson and Becker, 1987; Colborn et al., 1991; Gentry et al., 2002b).
Although it has consistent secretory effects on prolactin, TRH is not thought to be a normal
physiologic regulator of prolactin secretion. As evidence of this in horses, Pruett et al. (2003)
fed stallions 6-n-propyl-2-thiouracil to reduce thyroid hormone production (potentially
increasing endogenous TRH secretion by the hypothalamus), and prolactin secretion was not
altered.
Placing nonpregnant mares under artificial long photoperiods, simulating summer
conditions, in winter is a commonly used method for inducing earlier ovarian activity and
ovulation dates (Kooistra and Ginther, 1975; Sharp et al., 1975; Oxender et al., 1977).
Artificial lighting also stimulates an increase in prolactin concentration. Johnson and
Malinowski (1986) reported that just 2 h of artificial light during normal darkness of winter
increased plasma prolactin concentration in mares. Although effective, artificial photoperiods
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usually require more input of labor and modified facilities than most producers wish to invest,
thus alternative methods are constantly under investigation.
Pharmacologic methods of increasing prolactin secretion generally involve dopamine
antagonists. Dopamine antagonists have been reported to increase prolactin concentration
levels in the mare, especially during anestrus (Brendemuehl and Cross, 2000). Domperidone
increased prolactin concentration more than sulpiride in a project by Redmond et al. (1994).
Steroids have also been reported to affect prolactin levels. Thompson et al. (1991)
reported a 5-fold stimulation of prolactin storage in the pituitary by estradiol in ovariectomized
mares, whereas the effect on plasma concentrations was much less. Aurich et al. (1995)
reported an increase in prolactin concentration in overiectomized mares after administration of
estrogen plus naloxan, an opiod antagonist.
Dopamine and its antagonists
Dopamine is a catecholamine derived from tyrosine that can act either as a
neurohormone or a neurotransmitter (Hadley, 2000). As a neurohormone, dopamine is a
chemical messenger released into the bloodstream by nerve cells (Hadley, 2000). After
dopamine is released, it activates dopamine receptors, and the net effect is generally inhibitory
on post-synaptic neurons. Kebabian and Calne (1979) reported that dopamine has two receptor
subtypes: D-1 and D-2. The subtype involved with prolactin secretion from lactotropes is D-2
(Munemura et al., 1980; Creese et al., 1983). Western blot analysis and immunohistochemistry
with ovarian tissue from mares revealed that D-2 receptors were highly concentrated in CL
tissue and ovarian cortex, but were low in granulosa and theca cells; D-1 receptors were found
only in CL tissue (King et al., 2005). The authors suggested that dopamine may act directly on
the ovaries.
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Sulpiride is a widely used D-2 dopamine receptor antagonist that is cheap and readily
available. Johnson and Becker (1987) first reported that sulpiride stimulated prolactin secretion
in horses. Many studies have followed in mares (Nadal et al., 1997; Gentry et al., 2002a),
stallions (Colborn et al., 1991; Thomson et al., 1996), and geldings (Thompson and Depew,
1997). Remond et al. (1994) used sulpiride to increase prolactin levels to treat fescue toxicosis
in pregnant mares. In relation to non-treated mares, by 9 d after the start of treatment, the mares
treated with sulpiride had increased prolactin concentrations (Redmond et al., 1994). In a study
with seasonally anestrus mares treated with sulpiride daily, prolactin concentrations and
ovulation dates were measured (Besognet et al., 1997). The study showed that mean ovulation
date for sulpiride-treated mares was significantly earlier than for non-treated mares (Besognet et
al., 1997). These ovulations occurred on d 127 of the year, and mares continued to cycle
(Besognet et al., 1997). This group showed an increase in prolactin concentrations at 2 and 9 h
after sulpiride administration; prolactin returned to basal levels by 24 h. In an earlier study by
Besognet et al. (1997), 6 mares treated with sulpiride were bred during the first estrus along
with 6 non-treated mares, and it was found that sulpiride did not affect fertility.
Domperidone is a D-2 dopamine receptor antagonist that is orally active. It has been
used in human medicine to suppress nausea and vomiting (Dahlof and Hargreaves, 1998;
Cinquetti et al., 2000). In the horse, domperidone has been used to treat fescue toxicosis
because it increases prolactin concentrations. Given its positive effects on prolactin secretion,
domperidone has also been studied for its reproductive applications. Domperidone is rapidly
absorbed, but it does not cross the blood-brain barrier, and thus does not enter the central
nervous system (Champion et al., 1986). Redmond et al. (1994) reported a greater stimulation
of prolactin levels in mares treated with domperidone than in control mares and even sulpiride-
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treated mares. In a follow-up experiment, Brendemuehl and Cross (2000) treated anestrus
mares with domperidone for 55 d. By d 14 of treatment, mares receiving domperidone had
larger follicles than non-treated mares, and overall, had ovulation dates that were earlier and
prolactin levels that were higher.
Rationale for present experiments
Considerable interest exists in the breeding industry to induce early ovulation in order
to obtain foals earlier in the year. Administration of domperidone has yielded increased
prolactin levels and some success in inducing earlier ovulation dates in mares, however results
with sulpiride have been less successful. Estradiol is known to increase secretion and pituitary
storage of prolactin in ovariectomized mares, and may be the missing factor in sulpiride-treated,
seasonally anovulatory mares. Thus, the objective of the first experiment presented herein was
to test whether pretreatment with estradiol benzoate before treatment with daily sulpiride
injections would enhance the prolactin response, and hence the ovarian response, of seasonally
anovulatory mares. Given the positive response to estradiol observed in the first experiment,
the second experiment was designed to test whether estradiol pretreatment would enhance the
prolactin response to a single, 3-g injection of domperidone, which could potentially be used in
lieu of daily sulpiride injections in the winter stimulatory regimen. Experiment 2 was
performed in summer with normally cyclic mares.
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CHAPTER II
ESTRADIOL INTERACTION WITH SULPIRIDE IN SEASONALLY
ANOVULATORY MARES: EFFECTS ON PLASMA PROLACTIN
CONCENTRATIONS AND DATE OF FIRST OVULATION
Introduction
Prolactin seems to be an important factor in the timing of seasonal recrudescence of
anovulatory mares back into the breeding season. Treatment of seasonally anovulatory mares
with bovine prolactin (Nequin et al., 1993) or recombinant porcine prolactin (Thompson et al.,
1997) induced ovarian activity and ovulation significantly earlier in the year than occurred in
non-treated mares. Stimulation of endogenous prolactin secretion with dopamine antagonists
has also been reported to hasten the onset of follicular activity and ovulation, but to varying
degrees of success. Besognet et al. (1997) treated anovulatory mares with sulpiride beginning
February 5 and hastened ovulation by 33 d. In contrast, Donadeu and Thompson (2002) treated
mares with sulpiride from January 14 through February 14, and no mare ovulated within that
period of time. Using oral domperidone rather than sulpiride injections, Brendemuehl and
Cross (2000) treated mares beginning January 15 until ovulation and hastened mean date of
ovulation by 78 d.
Estradiol has been reported to increase prolactin secretion and pituitary prolactin content
in ovariectomized pony mares in summer (Thompson et al., 1991), although the effect of
estradiol on prolactin in the winter is unknown. It is possible that estrogen is the missing factor
resulting in less than ideal ovarian responses to sulpiride in seasonally anovulatory mares.
Thus, the present experiment was designed to test whether estradiol pretreatment of seasonally
anovulatory mares would enhance the prolactin and ovarian responses to a daily regimen of
sulpiride.
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Materials and methods
Animals and treatments. Eighteen mares were identified as seasonally anovulatory by
ultrasonographic examination of the ovaries in late December and early January; progesterone
concentrations were used after-the-fact to confirm the lack of ovulation or luteal tissue. All
mares were Quarter Horse or Thoroughbred type ranging in age from 7 to 17 yr with body
condition scores of 5.5 to 8 (Henneke et al., 1983). On January 11 (d 0), mares were randomly
allotted to 2 groups: estradiol-treated (n = 9) and controls (n = 9). Beginning on d 0, treated
mares received i.m. injections of 11 mg of estradiol benzoate (Sigma Chem. Co., St. Louis,
MO) in vegetable oil (2 mL) every other day for a total of 10 injections. Control mares received
equivalent injections of the vehicle. Beginning on d 11 (halfway through the estradiol and
vehicle treatments), all mares were started on a daily s.c. injection regimen of 250 mg of
sulpiride in 1 mL of vegetable shortening. Sulpiride injections were continued until a mare
ovulated or through d 45, whichever occurred first.
Samples of blood were collected by jugular venipuncture from each mare on the
mornings of d -1, 0, 1, 2, 5, and 11 (before treatments) and then every 3 d thereafter. Once a
mare displayed an ovarian follicle of at least 25 mm, blood samples were collected daily until 5
d after ovulation.
In addition to the routine morning blood samples, frequent blood samples (0, 1, 2, 4, 6,
8, and 12 h relative to injection of sulpiride or vehicle) were also collected on d 11, 13, 17, and
25 for characterization of the prolactin response to injections. Beginning on d 20, all mares had
their ovaries scanned every 3 d to assess follicular sizes; once a mare displayed an ovarian
follicle of at least 25 mm, she was scanned daily until ovulation.
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On the morning of d 24, all mares were catheterized in one jugular vein in preparation
for frequent blood sampling. Approximately 1 h later, 2 samples of blood were drawn from the
catheter 15 min apart (-15 and 0 min), and then TRH (Sigma) was administered (5 mg in 2 mL
saline). Blood samples were drawn at 15, 30, 45, 60, 90, 120, 150, 180, and 240 min relative to
TRH administration. On that day, sulpiride and vehicle injections were delayed until all
240-min samples were collected.
Blood sample collection and analysis. Routine morning blood samples were collected
into sodium heparin coated tubes (Vacutainer, Becton and Dickinson, Franklin Lakes, NJ).
Frequent samples collected through catheters were placed in 12 x 75 glass tubes containing 20
IU sodium heparin (Sigma). All blood samples were routinely centrifuged within 30 min of
collection; plasma was harvested and stored frozen.
Prolactin concentrations were estimated in plasma by radioimmunoassay previously
validated for horse tissues (Colborn et al., 1991). Plasma concentrations of
progesterone were measured with commercially available reagents (Diagnostic Systems
Laboratories, Webster, TX). Intra- and interassay CV and assay sensitivities were 7%, 12%,
and 0.2 ng/mL for prolactin and 5%, 8%, and 0.1 ng/mL for progesterone.
Statistical analyses. Data were analyzed by the Proc Mixed procedure of SAS (SAS
Institute Inc., Cary, NC). Data from daily and frequent sampling periods were analyzed for
effects of treatment, time, and treatment by time interactions with repeated measures. Single
point variables were analyzed via a one way ANOVA. For the periods of frequent sampling
(after sulpiride or TRH), the main effect of group and its interaction with time were analyzed
using the Proc Mixed procedures of SAS. When a significant F was detected (P < 0.05), the
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least significant difference (LSD) test (Steel et al., 1997) was used to determine differences
between groups within times.
Results
Before the onset of treatments, one control mare was found to have luteal tissue, as
indicated by high progesterone concentrations, and she was therefore dropped from the
experiment. After the cessation of sulpiride and vehicle injections, one control mare died as a
result of intestinal torsion, thus her date of ovulation was not available; all other data for her
were available and were included in the analyses.
Pretreatment of mares with estradiol benzoate before onset of sulpiride injections
increased (P < 0.001) prolactin concentrations in morning blood samples 10 to 15 ng/mL over
the concentrations in vehicle-treated mares beginning on d 12 (Figure 2.1). The differences in
prolactin concentrations between estradiol-treated and control mares persisted through d 35.
The frequent blood samples collected after morning injections on d 11, 13, 17, and 27
revealed that the difference (P < 0.001) in prolactin concentrations between estradiol-treated
and control mares increased from d 11 to d 17, after which it decreased on d 27 (Figure 2.2).
All means except for the -1 h and 0 samples on d 11 were different (P < 0.01) between
estradiol-treated and control mares.
Administration of TRH on d 24 revealed that the prolactin response to a different
prolactin secretagogue was also greater (P < 0.001) in mares pretreated with estradiol benzoate
relative to control mares (Figure 2.3).
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Figure 2.1. Mean plasma concentrations of prolactin over time for mares pretreated with
estradiol benzoate (Estradiol) or vehicle (Control) before onset of daily sulpiride treatment
(d 11 through 45). Prolactin levels differed (P < 0.001) between groups on days marked with an
asterisk.
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Figure 2.2. Mean plasma prolactin concentrations around the time of sulpiride injections on d
11 (first injection), 13, 17, and 25 in mares pretreated with estradiol benzoate (Estradiol) or
vehicle (Control). Prolactin concentrations were greater (P < 0.001; indicated by asterisks) in
estradiol-treated mares than in control mares for all time periods except -1 and 0 h on d 11.
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Figure 2.3. Mean plasma prolactin concentrations around the time of TRH administration on d
24 in mares pretreated with estradiol benzoate (Estradiol) or vehicle (Control). Prolactin
concentrations were greater (P < 0.001) in estradiol-treated mares than in control mares for all
time periods (indicated by asterisks).
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Mean ages, BCS, and dates of first ovulation for the two groups are presented in Table
2.1. Ages and BCS did not differ (P > 0.1) between groups. Mares pretreated with estradiol
benzoate ovulated an average of 45 d earlier (February 9th; P = 0.016) than control mares
(March 15th).
Discussion
Similar to the results of Donadeu and Thompson (2002), treatment of seasonally
anovulatory mares with sulpiride in vegetable shortening in the present experiment (control
mares) increased prolactin concentrations, but not to the degree reported for orally administered
domperidone (Brendemuehl and Cross, 2000). Moreover, it was revealed by frequent sampling
around the injections that the prolactin response to the first sulpiride injection in control mares
was much greater than it was after subsequent injections, even 2 d later. Thompson and Depew
(1997) reported a similar drop in the prolactin response to sulpiride administered to geldings in
March. They concluded that sulpiride stimulates secretion of prolactin from the pituitary gland,
but evidently did not stimulate production of prolactin in the long term.
Table 2.1. Mean age, body condition score (BCS), and day of first ovulation (based on
ultrasound exam and progesterone concentration) of mares pretreated with estradiol benzoate or
vehicle (control) before daily administration of sulpiride (d 11 to 45). Estradiol or vehicle
injections started on d 0 (January 11th).
Treatment group
Item

Controla

Estradiol-treatedb

SEM

P-value

Age

12.1

10.6

1.14

0.45

BCS

7.1

7.5

0.35

0.36

Day of first
ovulationc
73.6
29.0
11.6
a
N=7
b
N=9
c
Day of first ovulation relative to d 0 (January 11th)
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0.016

Pretreatment of mares in the present experiment with estradiol benzoate approximately
doubled the prolactin response to sulpiride after the first injection. This stimulation of prolactin
response was hypothesized based on the results of Thompson et al. (1991), who reported a 4- to
5-fold increase in prolactin content in the pituitary gland of ovariectomized pony mares
administered estradiol in oil for 21 d in the summer. Plasma concentrations of prolactin were
also stimulated transiently by estradiol treatment in that experiment (Thompson et al., 1991),
but only by 35% above controls. Thus, it is not surprising that estradiol treatment did not seem
to alter plasma prolactin concentrations in the present experiment until onset of sulpiride
injections.
By the third day of daily sulpiride injections, estradiol-treated mares had pre-injection
prolactin concentrations that were several-fold higher than control mares, indicating that the
prolactin response from the earlier sulpiride injections was lasting more than 24 h. Prolactin
concentrations in Figure 2.1 reflect pre-injection concentrations (the morning blood samples
were drawn before sulpiride injections), and it is evident that these concentrations were highest
on d 17 and 20. Prolactin concentrations seemed to decrease quickly after the cessation of
estradiol benzoate injections; however, the prolactin response to sulpiride on d 27 was still
considerably greater in mares that had received estradiol than in control mares. In fact,
prolactin in morning samples were elevated in estradiol-treated mares through d 35.
The TRH injection on d 24 was administered to determine whether stimulation by a
different secretagogue for prolactin would provide the same information on prolactin secretion
after estradiol treatment as revealed by the frequent sampling around sulpiride injections. In
other species, it has been shown that TRH causes the release of prolactin from lactotropes via
specific TRH receptors, distinctly different from dopaminergic receptors. The prolactin
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responses in both groups of mares were robust, and seemed to be greater than the prolactin
responses to sulpiride on d 27. This was particularly true for the control mares, and may
indicate a greater sensitivity of the lactotropes to TRH than to sulpiride at this time.
The greater prolactin response to sulpiride treatment in mares treated with estradiol
benzoate was associated with a significant hastening of date of first ovulation. Donadeu and
Thompson (2002), who treated mares with sulpiride under similar conditions, had no mares
ovulate during 28 d of treatment, although prolactin concentrations were increased to a degree
equal to that of the control mares in the present experiment. Thus, estradiol seemed to provide
the missing factor that was needed for hypersecretion of prolactin at this time of the year. In a
previous study of horses (Thompson et al., 1994), it was reported that mares and stallions had
greater resting prolactin concentrations than geldings, in which estrogen levels would be
minimal. In addition, Thompson et al. (1991) reported a direct stimulatory effect of estradiol
treatment on prolactin characteristics in ovariectomized pony mares.
It is concluded that estradiol treatment, similar to that in the present experiment, could
provide a useful method of increasing the reproductive response of seasonally anovulatory
mares to sulpiride administration. Given that Brendemuehl and Cross (2000) had equivalent
success with oral domperidone treatment, the question arises as to why sulpiride treatment,
without estradiol pretreatment, has not been as successful. Besognet et al. (1997) treated
anovulatory mares with sulpiride beginning February 5 and hastened ovulation by 33 d,
however it is not clear whether their mares were truly anovulatory or in the early transitional
period. The estradiol-treated mares in the present experiment ovulated on the 40th day of the
year on the average, which is February 9. Breeders normally start their breeding programs on
February 15 to provide a cushion between the subsequent foaling dates and January 1, before
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which they do not want to foal. Therefore the regimen with estradiol and sulpiride in the
present experiment seems applicable from the standpoint of timing of breeding in the industry.
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CHAPTER III
ESTRADIOL INTERACTION WITH A SINGLE INJECTION OF
DOMPERIDONE DURING THE BREEDING SEASON IN MARES:
PROLACTIN SECRETION AND REPRODUCTIVE TRAITS
Introduction
In Chapter II, it was shown that estradiol benzoate pretreatment of seasonally
anovulatory mares before a daily regimen of sulpiride increased the prolactin response to
sulpiride administration and significantly advanced the date of first ovulation. Thus, the
combination of estrogen and sulpiride has potential as a method of inducing ovulation in
seasonally quiescent mares. It is likely that the labor involved with daily injections of sulpiride
would preclude routine application of such a treatment regimen, thus a simpler alternative
method of stimulating prolactin secretion is required. Single-injection, depot administration of
compounds encased in bioerodible polymers has been described (Kraeling et al., 2000). The
objective of the present experiment was to test whether estradiol pretreatment would enhance
the prolactin response to a single, 3-g injection of domperidone in bioerodible polymer, which
could potentially be used in lieu of daily sulpiride injections in the winter stimulatory regimen.
This experiment was performed in the summer with mares of normal cyclicity.
Materials and methods
Animals and treatments. Fourteen seasonally cyclic mares ranging in age from 7 to 17
yr with BCS (Henneke et al., 1983) of 6.5 to 8.5 were randomly allotted to 2 treatment groups
of 7 mares each. Beginning July 25, they were checked for estrus with a vigorous stallion every
other day. Mares in diestrus for at least 6 d on August 2 were administered PGF2α (Lutalyse, 2
mg; Pharmacia & Upjohn Co., New York, NY) to induce luteolysis; mares in estrus or not
responding to the August 2 injection were administered PGF2α on August 8. Mares were started
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on treatments on the first day they were observed in estrus. Treatments were 1) estradiol
benzoate administration as described in Chapter II or 2) vehicle (vegetable oil) injection
administered in the same manner (controls). The first day of injection was d 0. On day 11, all
mares received an i.m. injection (40 mL) of domperidone (3 g) in bioerodible polymer (25%
lactide, 25% glycolide, and 50% domperidone).
Assessments and blood sampling. All mares were assessed for ovarian and follicular
sizes via transrectal ultrasonography every 3 d until the occurrence of a 25 mm follicle or
larger, after which the mare was assessed daily until ovulation or atresia of the dominant
follicle. Morning blood samples were drawn daily by jugular venipuncture starting on d 0 and
were continued until d 11; subsequent blood samples were taken every 3 d until d 46. Frequent
blood samples were drawn from all mares on d 11 at 0, 1, 3, 6, and 12 h relative to the
domperidone injections.
On d 21, all mares were catheterized in the morning and received an injection of TRH at
10 mg/kg BW in saline. Blood samples were drawn at -15, 0, 15, 30, 45, 60, 90, 120, 150, 180,
and 240 min relative to TRH injection.
Blood samples were collected via jugular venipuncture into sodium heparin coated tubes
(Vacutainer, Becton and Dickinson, Franklin Lakes, NJ). Blood samples were routinely
centrifuged within 30 min of collection and plasma was harvested and stored frozen.
Concentrations of prolactin and progesterone were measured in appropriate plasma samples as
described in Chapter II.
Statistical analyses. Data were analyzed by the Proc Mixed procedure of SAS (SAS
Institute Inc., Cary, NC). Data from daily and frequent sampling periods were analyzed for
effects of treatment, time, and treatment by time interactions with repeated measures. Single
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point variables were analyzed via a one-way ANOVA. When a significant F was detected
(P < 0.05), the least significant difference (LSD) test (Steel et al., 1997) was used to determine
differences between groups within time
Results
Treatment of mares with estradiol benzoate starting on the first day of estrus stimulated
(P < 0.05) plasma prolactin concentrations on d 2, 3, and 6 relative to controls (Figure 3.1).
Mares in both groups experienced an increase (P < 0.001) in plasma prolactin concentrations in
response to the single, 3-g injection of domperidone in bioerodible polymer on d 11 (Figure
3.2), and the response was higher (P < 0.01) in mares pretreated with estradiol benzoate relative
to controls at 1, 3, 6, and 12 h after injection. Plasma prolactin concentrations in mares
pretreated with estradiol benzoate remained severalfold higher (P < 0.05) than in control mares
through d 31 (Figure 3.1).
On d 21, before injection of TRH, plasma prolactin concentrations in mares pretreated
with estradiol benzoate were 3- to 4-fold greater (P < 0.05) than those in control mares (Figure
3.3). Prolactin concentrations after injection of TRH were also greater (P < 0.001) in estradioltreated mares.
Time to ovulation and other reproductive traits are presented in Table 3.1. Time from
onset of treatment until ovulation was similar (P > 0.1) in both groups. The time from onset of
treatment until return to estrus (determined by a drop in progesterone concentrations), time to
next CL formation, and time of second CL regression were not affected (P > 0.1) by estradiol
pretreatment.
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Figure 3.1. Mean plasma concentrations of prolactin over time for mares pretreated starting on
d 0 with estradiol benzoate (Estradiol) or vehicle (Control) before a single injection of
domperidone on d 11. Prolactin levels differed (P < 0.001) between groups on days marked
with an asterisk.
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Figure 3.2. Mean plasma prolactin concentrations around the time of domperidone injection on
d 11 in mares pretreated with estradiol benzoate (Estradiol) or vehicle (Control). Prolactin
concentrations were greater (P < 0.001; indicated by asterisks) in estradiol-treated mares than in
control mares for all periods after injection.

30

Prolactin, ng/mL

150

Control

*

100

50

Treated

*

*
* *

*

*

*
*

* *

0
0

50

100

150

200

250

Day

Figure 3.3. Mean plasma prolactin concentrations around the time of TRH administration on d
21 in mares pretreated with estradiol benzoate (Estradiol) or vehicle (Control). Prolactin
concentrations were greater (P < 0.001) in estradiol-treated mares than in control mares for all
time periods (indicated by asterisks).
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Table 3.1. Mean time to first ovulation, time until CL regression (as determined by a drop in
progesterone concentrations), time to next CL formation (high progesterone), and time of
second CL regression (drop in progesterone) of mares pretreated with estradiol benzoate or
vehicle (control) before a single injection of domperidone on d 11. Estradiol or vehicle
injections started on d 0 (first day of estrus).
Treatment groupa
Item

Control

Estradiol-treated

SEM

P-value

Days to
ovulation

6.8

6.4

0.68

0.66

Days to CL
regression

22.5

24.0

1.4

0.50

Days to second
ovulation

29.3

34.4

2.6

0.20

Days to second
CL regression
45.3
a
n = 7 per group.

48.2

1.3

0.14

Discussion
Similar to the results presented in Chapter II, pretreatment of cyclic mares in summer
with estradiol benzoate significantly enhanced the prolactin response to a single injection of
domperidone in bioerodible polymer. In fact, prolactin secretion in both groups of mares
increased in response to domperidone, and the duration of stimulation was 20 d. This
stimulation, if repeatable in seasonally anovulatory mares in winter, should be long enough such
that this single-injection regimen could replace the daily sulpiride injections used in Chapter II;
mares in Chapter II ovulated an average of 18 d after onset of sulpiride injections.
Estradiol pretreatment also increased prolactin concentrations in mares before the
domperidone injection, at least in 3 of 10 morning blood samples collected during this time (see
Figure 3.1). As reported by Thompson et al. (1991), estradiol treatment for 21 d had only a
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moderate and transitory effect on plasma prolactin concentrations, but increased pituitary
prolactin content severalfold at the end of treatment. Thus, it is possible that the stimulatory
effect of estradiol on prolactin secretion may go unnoticed without an extra stimulus, such as
sulpiride or domperidone injection. This may explain why Johnson (1986) reported no change
in plasma prolactin concentrations across the estrous cycle in mares during the breeding season.
It is interesting to note that treatment of mares with estradiol benzoate did not alter the
timing of ovulation during treatment nor the timing of CL regression of the subsequent diestrus.
Estradiol is a potent inhibitor of FSH secretion in horses (Thompson et al., 1979; Garza et al.,
1986), and when given at sufficiently high doses, prevents follicular growth (Woodley et al.,
1979). Given the every-other-day injection regimen, the last injection of estradiol benzoate was
on d 19, a day or two before regression of the CL from the first diestrus. Thompson (1978)
reported that estradiol benzoate injections, as administered here, increased estradiol
concentrations in peripheral plasma of geldings to a peak of approximately 60 to 70 pg/mL at
24 h; concentrations gradually decreased to 25 pg/mL 48 h after injection. Apparently, the dose
of estradiol benzoate used in this experiment was not high enough to suppress FSH secretion
sufficiently to inhibit follicular growth in preparation for the subsequent (second) estrus. The
dose in the present experiment was 11 mg estradiol benzoate every other day, whereas the dose
used by Woodley et al. (1979), which inhibited follicular growth, was 10 mg daily.
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SUMMARY AND CONCLUSIONS
Two experiments were performed to study the possibility of using estradiol pretreatment
to enhance prolactin secretion in response to a dopamine receptor antagonist, and to determine
if such enhancement increased the success rate of sulpiride treatment for inducing ovarian
activity and ovulation in seasonally anovulatory mares. In the first experiment, pretreatment
with estradiol benzoate greatly increased the prolactin response to subsequent daily injections of
sulpiride. This increase in prolactin response was associated with a significant hastening of the
date of ovulation relative to control mares. It was concluded that the combined treatment of
estradiol and sulpiride provides a potential practical basis for preparing nonpregnant,
anovulatory mares for breeding on February 15.
Because daily injections of sulpiride might prove too labor intensive to be practical, the
second experiment tested the possibility of using a single injection of 3 g of domperidone in
bioerodible polymer in lieu of daily sulpiride injections for the stimulation of prolactin
secretion. The first experiment was basically repeated with mares in the summer, using the first
day of estrus as the starting point for treatment. As in the first experiment, pretreatment with
estradiol benzoate enhanced the prolactin response to the injected domperidone, which itself
seemed to stimulate prolactin secretion in both groups of mares for 20 d. Estradiol pretreatment
did not alter reproductive traits in these mares. It was concluded that the single injection of
domperidone likely could replace the daily sulpiride injections used in the first experiment,
thereby making that regimen more practical for on-farm use. This possibility needs to be
confirmed in future experiments.
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